Canada's Research-Based Pharmaceutical Companies invested over a billion dollars in research and development (R&D) in 2007
But opportunities exist for further growth, says Rx&D
23-Jun-2008 -
Canada's Research-Based Pharmaceutical Companies President Russell Williams issued the following statement from BIO 2008 in reaction to the release of the Patented Medicine Prices Review Board's (PMPRB) Annual Report on R&D-to-sales ratio in the pharmaceutical industry.
"As the global ...
biotechnology
medicine
vaccines